- Home
- Publications
- Publication Search
- Publication Details
Title
The potential of miRNAs as biomarkers for multiple myeloma
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 14, Issue 8, Pages 947-959
Publisher
Informa UK Limited
Online
2014-08-07
DOI
10.1586/14737159.2014.946906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
- (2014) Alberto Rocci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7
- (2014) W. A. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
- (2013) A. Ferrajoli et al. BLOOD
- Circulating microRNAs as potential new biomarkers for prostate cancer
- (2013) A Sita-Lumsden et al. BRITISH JOURNAL OF CANCER
- Improved risk stratification in myeloma using a microRNA-based classifier
- (2013) Ping Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia
- (2013) M. Lionetti et al. CLINICAL CANCER RESEARCH
- Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
- (2013) Irfana Muqbil et al. CURRENT DRUG TARGETS
- Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
- (2013) Verena Köberle et al. EUROPEAN JOURNAL OF CANCER
- Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
- (2013) L. Kubiczkova et al. HAEMATOLOGICA
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia:miR-155Upregulation Independently Identifies High-Risk Patients
- (2013) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications
- (2013) C C Bjorklund et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
- (2013) Anthony W. Gebhard et al. MOLECULAR CANCER THERAPEUTICS
- EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
- (2013) Jia Shen et al. NATURE
- Disruption of microRNA Biogenesis Confers Resistance to ER Stress-Induced Cell Death Upstream of the Mitochondrion
- (2013) Karen Cawley et al. PLoS One
- Trash or Treasure: extracellular microRNAs and cell-to-cell communication
- (2013) Nobuyoshi Kosaka et al. Frontiers in Genetics
- Exosomal tumor-suppressive microRNAs as novel cancer therapy
- (2012) Nobuyoshi Kosaka et al. ADVANCED DRUG DELIVERY REVIEWS
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
- (2012) C I Jones et al. BRITISH JOURNAL OF CANCER
- miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF
- (2012) Chun-Yan Sun et al. CARCINOGENESIS
- Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
- (2012) C. F. de Larrea et al. CLINICAL CANCER RESEARCH
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
- (2012) Pieter Sonneveld et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype
- (2012) A Rio-Machin et al. LEUKEMIA
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
- (2012) M. Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation
- (2011) G. J. Morgan et al. BLOOD
- miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
- (2011) R. Visone et al. BLOOD
- A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
- (2011) Fabrizio Bianchi et al. EMBO Molecular Medicine
- Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
- (2011) G. J. Morgan et al. HAEMATOLOGICA
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA signatures characterize multiple myeloma patients
- (2011) S L Corthals et al. LEUKEMIA
- Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
- (2011) S K Kumar et al. LEUKEMIA
- Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants
- (2011) Jr-Shiuan Yang et al. MOLECULAR CELL
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
- (2011) S. Melo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia
- (2011) E. Moussay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Early Treatment Strategies for High-Risk Myeloma Precursor Disease in the Future
- (2011) Ola Landgren et al. SEMINARS IN HEMATOLOGY
- MicroRNAs: New Players in Multiple Myeloma
- (2011) Flavia Pichiorri et al. Frontiers in Genetics
- The prognostic and functional role of microRNAs in acute myeloid leukemia
- (2010) G. Marcucci et al. BLOOD
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
- (2010) B. A. Walker et al. BLOOD
- Multiple myeloma: biology of the disease
- (2010) Anuj Mahindra et al. BLOOD REVIEWS
- A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
- (2010) Sonia A. Melo et al. CANCER CELL
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients
- (2010) M. E. Sarasquete et al. HAEMATOLOGICA
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers
- (2010) Min S Kim et al. JOURNAL OF PATHOLOGY
- Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
- (2010) N C Gutiérrez et al. LEUKEMIA
- Posttranscriptional Regulation of MicroRNA Biogenesis in Animals
- (2010) Haruhiko Siomi et al. MOLECULAR CELL
- Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration
- (2010) Yujing Zhang et al. MOLECULAR CELL
- High-risk myeloma is associated with global elevation of miRNAs and overexpression ofEIF2C2/AGO2
- (2010) Yiming Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma
- (2010) Brendan M Weiss et al. Expert Review of Hematology
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma
- (2009) Sophie L. Corthals et al. LEUKEMIA RESEARCH
- Modulation of microRNA processing by p53
- (2009) Hiroshi I. Suzuki et al. NATURE
- A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
- (2009) Sonia A Melo et al. NATURE GENETICS
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- DICER1 Mutations in Familial Pleuropulmonary Blastoma
- (2009) D. A. Hill et al. SCIENCE
- Small-molecule inhibitors of MDM2 as new anticancer therapeutics
- (2009) Michael P. Dickens et al. SEMINARS IN CANCER BIOLOGY
- SMAD proteins control DROSHA-mediated microRNA maturation
- (2008) Brandi N. Davis et al. NATURE
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search